Abstract
In order to treat severe acute respiratory syndrome coronavirus (SARS-CoV), till now, no such specific treatment is available. Various coronaviruses (CoV) such as SARS-CoV, MERS-CoV (Middle East Respiratory Syndrome), and SARS-CoV-2 can infect humans and the name was implicated due to their crown shape. SARS-CoV-2 is also called COVID-19 which was found to be a novel strain of coronavirus and is transmitted primarily through small droplets of viral particles that target the human body through the open pathways. Researchers have observed that microbes can survive for a longer duration as they get adhered to any object or surface. Nanoparticles have the capability to disable these pathogens even before they enter the body. To eradicate conventional time consuming steps like quantitative real-time polymerase chain reaction for detection of COVID-19, nanoparticles mediated sensing approaches provide great advances in rapid diagnosis. Nanoparticles- based biosensors are comparatively beneficial which offer tremendous potential for rapid medical diagnosis. Nanotechnology can be refined and optimized to attack a wide variety of pathogens. As compared to other large molecular structures, nanoparticles being small in size, have high sensitivity for bio-sensing and can move throughout the body without disruption of the immune function.
Keywords: SARS-CoV, COVID-19, nanoparticles, nanotechnology, antiviral therapy, bio-sensing.
Current Pharmaceutical Design
Title:Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19
Volume: 27 Issue: 32
Author(s): Pallavi S. Chauhan, Dhananjay Yadav*, Anuj Dubey and Jun-O Jin*
Affiliation:
- Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541,South Korea
- Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541,South Korea
Keywords: SARS-CoV, COVID-19, nanoparticles, nanotechnology, antiviral therapy, bio-sensing.
Abstract: In order to treat severe acute respiratory syndrome coronavirus (SARS-CoV), till now, no such specific treatment is available. Various coronaviruses (CoV) such as SARS-CoV, MERS-CoV (Middle East Respiratory Syndrome), and SARS-CoV-2 can infect humans and the name was implicated due to their crown shape. SARS-CoV-2 is also called COVID-19 which was found to be a novel strain of coronavirus and is transmitted primarily through small droplets of viral particles that target the human body through the open pathways. Researchers have observed that microbes can survive for a longer duration as they get adhered to any object or surface. Nanoparticles have the capability to disable these pathogens even before they enter the body. To eradicate conventional time consuming steps like quantitative real-time polymerase chain reaction for detection of COVID-19, nanoparticles mediated sensing approaches provide great advances in rapid diagnosis. Nanoparticles- based biosensors are comparatively beneficial which offer tremendous potential for rapid medical diagnosis. Nanotechnology can be refined and optimized to attack a wide variety of pathogens. As compared to other large molecular structures, nanoparticles being small in size, have high sensitivity for bio-sensing and can move throughout the body without disruption of the immune function.
Export Options
About this article
Cite this article as:
Chauhan S. Pallavi , Yadav Dhananjay*, Dubey Anuj and Jin Jun-O*, Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19, Current Pharmaceutical Design 2021; 27 (32) . https://dx.doi.org/10.2174/1381612827666210203142934
DOI https://dx.doi.org/10.2174/1381612827666210203142934 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy
Current Medicinal Chemistry The Chemistry of Mycophenolic Acid - Synthesis and Modifications Towards Desired Biological Activity
Current Medicinal Chemistry A QSAR Study of Biphenyl Analogues of 2-Nitroimidazo-[2, 1-b] [1, 3] - oxazines as Antitubercular Agents Using Genetic Function Approximation
Medicinal Chemistry Lipid-Based Nanocarriers for CNS-Targeted Drug Delivery
Recent Patents on CNS Drug Discovery (Discontinued) Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives
Medicinal Chemistry CoMFA and CoMSIA 3D QSAR Models for a Series of Cyclic Imides with Analgesic Activity
Medicinal Chemistry Vitamin D: Production, Metabolism, and Impact on Human Health
Current Nutrition & Food Science Heptahelical and Other G-Protein-Coupled Receptors (GPCRs) Signaling
Current Medicinal Chemistry Lipase-Catalyzed Dynamic Combinatorial Resolution and the Synthesis of Heteroaromatic Cyanohydrin Ester Enantiomers
Current Organic Chemistry Designing Peptide Mimetics for the Treatment of Multiple Sclerosis
Mini-Reviews in Medicinal Chemistry Other Activities
Current Bioactive Compounds Optical Chemical Biosensors for High Throughput Screening of Drugs
Combinatorial Chemistry & High Throughput Screening Macrocyclic trichothecenes as antifungal and anticancer compounds
Current Medicinal Chemistry Dynamic Imaging Changes of COVID-19 Pneumonia at Different Stages
Current Medical Imaging Hydroxychloroquine (HCQ) and its Synthetic Precursors: A Review
Mini-Reviews in Organic Chemistry Biological Carrier Molecules of Radiopharmaceuticals for Molecular Cancer Imaging and Targeted Cancer Therapy
Current Pharmaceutical Design Author Index To Volume 3
Current Topics in Medicinal Chemistry Synthesis and In Vitro Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent Antiglioma Agents
Anti-Cancer Agents in Medicinal Chemistry Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
Current Cardiology Reviews Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer
Current Drug Targets